The European Commission has approved Sanofi’s Teizeild as the first disease-modifying therapy in the EU to delay the onset of stage 3 type 1 diabetes in adults and children with stage 2 T1D. Supported ...
A new University of Helsinki study shows that exposure to indoor air pollution from solid fuels during childhood may have lasting effects on cognitive health, with impairments becoming evident decades ...
Artsy limited editions, unusual open-frame designs, retro throwbacks, and bold new ideas made this a standout year for the PC ...
4dOpinion
An Act of Cosmic Sabotage
If scientists are able to inspect it in person, and they find that Mars was indeed once alive with microbes, we would know ...
The NBNB initiative targets compliant RWA infrastructure on BNB Chain, but commercialization remains unproven with no clear ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback